TradeWorx’s Vertex Pharmaceuticals VRTX Stock Holding History

TradeWorx’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-8,793	Closed	-$667K	–	615
2013 Q3	$667K	Buy	+8,793	New	+$700K	0.31%	103

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TradeWorx's VRTX Position: Q4 2013 in Review

TradeWorx sold out of Vertex Pharmaceuticals (VRTX) in Q4 2013, closing a stake of 8,793 shares — an estimated $667K sold.

TradeWorx first reported a position in VRTX in Q3 2013 and held it in 1 quarter. The position peaked at $667K in Q3 2013. 387 funds tracked by Wall St. Rank hold VRTX as of Q4 2013.

TradeWorx reported no remaining Vertex Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
TradeWorx sold 8,793 Vertex Pharmaceuticals shares in Q4 2013, an estimated $667K.
TradeWorx first reported a position in Vertex Pharmaceuticals in Q3 2013 and held it in 1 quarter.
TradeWorx's Vertex Pharmaceuticals position peaked at $667K in Q3 2013.
387 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2013.

Based on TradeWorx's 13F filing for Q4 2013, filed 18 Feb 2014.